[Clinical efficiency of milrdonate in combined treatment of peripheral diabetic (sensory-motor) neuropathy].
Statsenko
M E
ME
Poletaeva
L V
LV
Turkina
S V
SV
Inozemtseva
M A
MA
Apukhtin
A F
AF
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000368:Aged; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004576:Electromyography; D005260:Female; D006801:Humans; D008297:Male; D008763:Methylhydrazines / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D011788:Quality of Life; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D008763:Methylhydrazines; C050147:3-(2,2,2-trimethylhydrazine)propionate